Shelby Sharrone Orange, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15331 W Bell Rd Ste 212, Surprise, AZ 85374 Phone: 480-310-0647 |
Matthew Barker, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 15241 W Old Oak Ln, Surprise, AZ 85379 Phone: 801-336-8016 |
Lauren S Garcia, RN, IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 14384 N 136th Ln, Surprise, AZ 85379 Phone: 602-373-6854 |
Jayme Ulrich, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 14821 W Pershing St, Surprise, AZ 85379 Phone: 623-203-0121 |
Kristin Smith, Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 15802 N Parkview Pl, Surprise, AZ 85374 Phone: 623-876-7923 |
Melissa Blevans, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 13825 W Desert Cove Rd, Surprise, AZ 85379 Phone: 503-876-7160 |
Kristen Maw Alyassiri, RN, BSN, MSN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 14120 W Mandalay Ln, Surprise, AZ 85379 Phone: 319-202-3809 |
Tesha Marie Hopphaus, NP Registered Nurse Medicare: Medicare Enrolled Practice Location: 17674 N Litchfield Rd, Surprise, AZ 85374 Phone: 623-281-3001 Fax: 623-281-3003 |
Mrs. Kathleen A Sacco-ramirez, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 13700 W Greenway Rd, Surprise, AZ 85374 Phone: 623-876-7704 |
Lisa Marie Young, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15150 W Mondell Rd, Surprise, AZ 85374 Phone: 623-876-7604 Fax: 623-876-7605 |
Ms. Crystal Marie Linhares, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 14206 W Aster Dr, Surprise, AZ 85379 Phone: 209-518-8411 |
Nichole Howard, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15430 W Jenan Dr, Surprise, AZ 85379 Phone: 623-552-1742 |
Ms. Francisca Melissa Olibarria, FNP-C Registered Nurse - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 15351 W Bell Rd, Surprise, AZ 85374 Phone: 877-809-5092 |
Larry Williams, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 15348 W Calavar Rd, Surprise, AZ 85379 Phone: 623-229-5707 |
Mr. Hollie Elaine Perlow-schmidt, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 17752 W Acapulco Ln, Surprise, AZ 85388 Phone: 623-824-1095 |
Mrs. Judy Anne Kappel, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 15802 N. Parkview Place, Surprise, AZ 85379 Phone: 623-764-0425 |
Amy Kathleen Serkland, RN, BSN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 14395 W Voltaire St, Surprise, AZ 85379 Phone: 520-233-7111 |
Nelida Fructuozo, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 15802 N Parkview Pl, Surprise, AZ 85374 Phone: 623-523-8004 |
Judith Carrie Craig, R.N. Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 15550 N Parkview Pl, Surprise, AZ 85374 Phone: 623-523-8840 Fax: 623-523-8811 |
Tamara Richardson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15802 N Parkview Pl, Surprise, AZ 85374 Phone: 623-523-8204 |
News Archive
When developing new drugs, monitoring cellular responses to candidate compounds is essential for assessing their efficacy and safety. Researchers from the RIKEN Center for Life Science Technologies report a new method to monitor and quantify the activity of gene promoters during the response to a drug, using the advanced gene expression analysis method CAGE followed by single-molecule sequencing.
Salix Pharmaceuticals, Ltd. today announced the presentation of two analyses of data from its Phase 3 pivotal clinical trials, TARGET 1 and 2, demonstrating a 14-day course of XIFAXAN 550 mg (rifaximin) taken three times daily achieved adequate relief of symptoms of non-constipation irritable bowel syndrome (non-C IBS) in a significantly greater proportion of patients compared with placebo.
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product.
After over a century of development, cancer immunotherapy (CIT) has risen to become a promising approach for treating cancer. Unlike conventional methods that try to kill cancer cells directly, CIT involves modifying or stimulating the immune system's natural ability to fight the disease. So far, various CIT treatments have shown remarkable results in terms of survival rates, and many new and combination strategies are currently under study.
› Verified 2 days ago